Clinical Trial Update: Apatinib for Extensive Stage Small Cell Lung Cancer After Second/Third Line Chemotherapy. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating apatinib for extensive-stage small cell lung cancer after second/third line chemotherapy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Fan Yun, MD | Conditions: Small Cell Lung Cancer | Phase 2 | Status: COMPLETED